Nystatin bulk powder recall due to incorrect assay strength label
Fagron, Inc. is recalling Nystatin 5BU bulk powder for prescription compounding due to an incorrect assay strength label. The product was distributed to pharmacies and repacker/relabelers in the United States and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves incorrect pharmaceutical potency labeling on a compounding ingredient, which creates a risk of harm through incorrect dosing in compounded medications. No illnesses or injuries have been reported. This qualifies as a risk-of-harm product without reported injury, corresponding to High severity.
Plain-English summary
Fagron, Inc. is recalling 13 containers of Nystatin 5BU (Activity: 6482 Units/mg) bulk powder for prescription compounding. The recall is due to an incorrect assay value listed on the product label.
The recalled product (Lot 230308-U46196, expiration date 04/30/2025, NDC 51552-0041-5) was distributed to one distributor, which may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada for use in prescription compounding.
Healthcare professionals and compounding pharmacies who have received this product should verify the actual assay value with Fagron, Inc. before using the product for compounding. Patients who have received medications compounded using this ingredient should consult with their healthcare provider or pharmacist if they have concerns.
The recalled product
- Product
- NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-5 Bar code 3 51552 00415 3
- Manufacturer
- Fagron, Inc
- Affected units
- 13
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 230308-U46196
- Exp. date 04/30/2025
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 4 recalled by Fagron, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin Bulk Powder Recalled Due to Incorrect Label Strength
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- ModeratePrescription Compounding Drug Nandrolone Decanoate Recalled for Subpotency
FDA (Drugs) · 2022-05-18
- ModerateFDA Recalls Subpotent Nandrolone Decanoate Compounding Ingredient
FDA (Drugs) · 2022-05-18
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02